img

Global and India Pandemic Influenza Vaccine Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and India Pandemic Influenza Vaccine Market Report & Forecast 2024-2034

The global Pandemic Influenza Vaccine revenue was US$ 7829.8 million in 2022 and is forecast to a readjusted size of US$ 11790 million by 2029 with a CAGR of 5.5% during the forecast period (2024-2034).
In India, the Pandemic Influenza Vaccine revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2024-2034).
Global key players of Pandemic Influenza Vaccine include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.
This report focuses on global and India Pandemic Influenza Vaccine market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2024, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Pandemic Influenza Vaccine will continue to grow rapidly in the future.
Global Pandemic Influenza Vaccine Scope and Market Size
Pandemic Influenza Vaccine market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Pandemic Influenza Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For India market, this report focuses on the Pandemic Influenza Vaccine market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.



By Company


Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine

Segment by Application


6 Months to 3 Years
> 3 Years
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Pandemic Influenza Vaccine definition, global sales (volume and revenue), India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Pandemic Influenza Vaccine companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Pandemic Influenza Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pandemic Influenza Vaccine sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Pandemic Influenza Vaccine Product Introduction
1.2 Global Pandemic Influenza Vaccine Outlook 2018 VS 2022 VS 2029
1.2.1 Global Pandemic Influenza Vaccine Sales in US$ Million for the Year 2018-2029
1.2.2 Global Pandemic Influenza Vaccine Sales in Volume for the Year 2018-2029
1.3 India Pandemic Influenza Vaccine Outlook 2018 VS 2022 VS 2029
1.3.1 India Pandemic Influenza Vaccine Sales in US$ Million for the Year 2018-2029
1.3.2 India Pandemic Influenza Vaccine Sales in Volume for the Year 2018-2029
1.4 Pandemic Influenza Vaccine Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4.1 The Market Share of India Pandemic Influenza Vaccine in Global, 2018 VS 2022 VS 2029
1.4.2 The Growth Rate of Pandemic Influenza Vaccine Market Size, India VS Global, 2018 VS 2022 VS 2029
1.5 Pandemic Influenza Vaccine Market Dynamics
1.5.1 Pandemic Influenza Vaccine Industry Trends
1.5.2 Pandemic Influenza Vaccine Market Drivers
1.5.3 Pandemic Influenza Vaccine Market Challenges
1.5.4 Pandemic Influenza Vaccine Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Pandemic Influenza Vaccine by Type
2.1 Pandemic Influenza Vaccine Market Segment by Type
2.1.1 Trivalent Influenza Vaccine
2.1.2 Quadrivalent Influenza Vaccine
2.2 Global Pandemic Influenza Vaccine Market Size by Type
2.2.1 Global Pandemic Influenza Vaccine Sales in Value, by Type (2018, 2022 & 2029)
2.2.2 Global Pandemic Influenza Vaccine Sales in Volume, by Type (2018, 2022 & 2029)
2.2.3 Global Pandemic Influenza Vaccine Average Selling Price (ASP) by Type (2018, 2022 & 2029)
2.3 India Pandemic Influenza Vaccine Market Size by Type
2.3.1 India Pandemic Influenza Vaccine Sales in Value, by Type (2018, 2022 & 2029)
2.3.2 India Pandemic Influenza Vaccine Sales in Volume, by Type (2018, 2022 & 2029)
2.3.3 India Pandemic Influenza Vaccine Average Selling Price (ASP) by Type (2018, 2022 & 2029)
3 Pandemic Influenza Vaccine by Application
3.1 Pandemic Influenza Vaccine Market Segment by Application
3.1.1 6 Months to 3 Years
3.1.2 > 3 Years
3.2 Global Pandemic Influenza Vaccine Market Size by Application
3.2.1 Global Pandemic Influenza Vaccine Sales in Value, by Application (2018, 2022 & 2029)
3.2.2 Global Pandemic Influenza Vaccine Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 Global Pandemic Influenza Vaccine Average Selling Price (ASP) by Application (2018, 2022 & 2029)
3.3 India Pandemic Influenza Vaccine Market Size by Application
3.3.1 India Pandemic Influenza Vaccine Sales in Value, by Application (2018, 2022 & 2029)
3.3.2 India Pandemic Influenza Vaccine Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 India Pandemic Influenza Vaccine Average Selling Price (ASP) by Application (2018, 2022 & 2029)
4 Global Pandemic Influenza Vaccine Competitor Landscape by Company
4.1 Global Pandemic Influenza Vaccine Market Size by Company
4.1.1 Global Key Manufacturers of Pandemic Influenza Vaccine, Ranked by Revenue (2022)
4.1.2 Global Pandemic Influenza Vaccine Revenue by Manufacturer (2018-2024)
4.1.3 Global Pandemic Influenza Vaccine Sales by Manufacturer (2018-2024)
4.1.4 Global Pandemic Influenza Vaccine Price by Manufacturer (2018-2024)
4.2 Global Pandemic Influenza Vaccine Concentration Ratio (CR)
4.2.1 Pandemic Influenza Vaccine Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Pandemic Influenza Vaccine in 2022
4.2.3 Global Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Pandemic Influenza Vaccine, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Pandemic Influenza Vaccine, Product Offered and Application
4.5 Global Key Manufacturers of Pandemic Influenza Vaccine, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Pandemic Influenza Vaccine Market Size by Company
4.7.1 Key Players of Pandemic Influenza Vaccine in India, Ranked by Revenue (2022)
4.7.2 India Pandemic Influenza Vaccine Revenue by Players (2018-2024)
4.7.3 India Pandemic Influenza Vaccine Sales by Players (2018-2024)
5 Global Pandemic Influenza Vaccine Market Size by Region
5.1 Global Pandemic Influenza Vaccine Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Pandemic Influenza Vaccine Market Size in Volume by Region (2018-2029)
5.2.1 Global Pandemic Influenza Vaccine Sales in Volume by Region: 2018-2024
5.2.2 Global Pandemic Influenza Vaccine Sales in Volume Forecast by Region (2024-2029)
5.3 Global Pandemic Influenza Vaccine Market Size in Value by Region (2018-2029)
5.3.1 Global Pandemic Influenza Vaccine Sales in Value by Region: 2018-2024
5.3.2 Global Pandemic Influenza Vaccine Sales in Value by Region: 2024-2029
6 Americas
6.1 Americas Pandemic Influenza Vaccine Market Size YoY Growth 2018-2029
6.2 Americas Pandemic Influenza Vaccine Sales in Volume, by Type (2018, 2022 & 2029)
6.3 Americas Pandemic Influenza Vaccine Sales in Volume, by Application (2018, 2022 & 2029)
6.4 Americas Pandemic Influenza Vaccine Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 Americas Pandemic Influenza Vaccine Sales in Value by Country (2018, 2022 & 2029)
6.4.2 Americas Pandemic Influenza Vaccine Sales in Volume by Country (2018, 2022 & 2029)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Pandemic Influenza Vaccine Market Size YoY Growth 2018-2029
7.2 EMEA Pandemic Influenza Vaccine Sales in Volume, by Type (2018, 2022 & 2029)
7.3 EMEA Pandemic Influenza Vaccine Sales in Volume, by Application (2018, 2022 & 2029)
7.4 EMEA Pandemic Influenza Vaccine Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 EMEA Pandemic Influenza Vaccine Sales in Value by Country (2018, 2022 & 2029)
7.4.2 EMEA Pandemic Influenza Vaccine Sales in Volume by Country (2018, 2022 & 2029)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Pandemic Influenza Vaccine Market Size YoY Growth 2018-2029
8.2 China Pandemic Influenza Vaccine Sales in Volume, by Type (2018, 2022 & 2029)
8.3 China Pandemic Influenza Vaccine Sales in Volume, by Application (2018, 2022 & 2029)
9 APAC
9.1 APAC Pandemic Influenza Vaccine Market Size YoY Growth 2018-2029
9.2 APAC Pandemic Influenza Vaccine Sales in Volume, by Type (2018, 2022 & 2029)
9.3 APAC Pandemic Influenza Vaccine Sales in Volume, by Application (2018, 2022 & 2029)
9.4 APAC Pandemic Influenza Vaccine Market Facts & Figures by Region (2018, 2022 & 2029)
9.4.1 APAC Pandemic Influenza Vaccine Sales in Value by Region (2018, 2022 & 2029)
9.4.2 APAC Pandemic Influenza Vaccine Sales in Volume by Region (2018, 2022 & 2029)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Description and Business Overview
10.1.3 Sanofi Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Sanofi Pandemic Influenza Vaccine Products Offered
10.1.5 Sanofi Recent Development
10.2 CSL
10.2.1 CSL Company Information
10.2.2 CSL Description and Business Overview
10.2.3 CSL Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 CSL Pandemic Influenza Vaccine Products Offered
10.2.5 CSL Recent Development
10.3 GSK
10.3.1 GSK Company Information
10.3.2 GSK Description and Business Overview
10.3.3 GSK Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 GSK Pandemic Influenza Vaccine Products Offered
10.3.5 GSK Recent Development
10.4 Viatris
10.4.1 Viatris Company Information
10.4.2 Viatris Description and Business Overview
10.4.3 Viatris Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Viatris Pandemic Influenza Vaccine Products Offered
10.4.5 Viatris Recent Development
10.5 AstraZeneca
10.5.1 AstraZeneca Company Information
10.5.2 AstraZeneca Description and Business Overview
10.5.3 AstraZeneca Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 AstraZeneca Pandemic Influenza Vaccine Products Offered
10.5.5 AstraZeneca Recent Development
10.6 Hualan Bio
10.6.1 Hualan Bio Company Information
10.6.2 Hualan Bio Description and Business Overview
10.6.3 Hualan Bio Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Hualan Bio Pandemic Influenza Vaccine Products Offered
10.6.5 Hualan Bio Recent Development
10.7 Changchun Institute of Biological
10.7.1 Changchun Institute of Biological Company Information
10.7.2 Changchun Institute of Biological Description and Business Overview
10.7.3 Changchun Institute of Biological Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Changchun Institute of Biological Pandemic Influenza Vaccine Products Offered
10.7.5 Changchun Institute of Biological Recent Development
10.8 Sinovac
10.8.1 Sinovac Company Information
10.8.2 Sinovac Description and Business Overview
10.8.3 Sinovac Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Sinovac Pandemic Influenza Vaccine Products Offered
10.8.5 Sinovac Recent Development
10.9 BCHT
10.9.1 BCHT Company Information
10.9.2 BCHT Description and Business Overview
10.9.3 BCHT Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.9.4 BCHT Pandemic Influenza Vaccine Products Offered
10.9.5 BCHT Recent Development
10.10 Jiangsu GDK
10.10.1 Jiangsu GDK Company Information
10.10.2 Jiangsu GDK Description and Business Overview
10.10.3 Jiangsu GDK Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Jiangsu GDK Pandemic Influenza Vaccine Products Offered
10.10.5 Jiangsu GDK Recent Development
10.11 KM Biologics
10.11.1 KM Biologics Company Information
10.11.2 KM Biologics Description and Business Overview
10.11.3 KM Biologics Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.11.4 KM Biologics Pandemic Influenza Vaccine Products Offered
10.11.5 KM Biologics Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Pandemic Influenza Vaccine Industry Chain Analysis
11.2 Pandemic Influenza Vaccine Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Pandemic Influenza Vaccine Production Mode & Process
11.4 Pandemic Influenza Vaccine Sales and Marketing
11.4.1 Pandemic Influenza Vaccine Sales Channels
11.4.2 Pandemic Influenza Vaccine Distributors
11.5 Pandemic Influenza Vaccine Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Pandemic Influenza Vaccine CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
Table 2. Pandemic Influenza Vaccine Market Trends
Table 3. Pandemic Influenza Vaccine Market Drivers
Table 4. Pandemic Influenza Vaccine Market Challenges
Table 5. Pandemic Influenza Vaccine Market Restraints
Table 6. Global Pandemic Influenza Vaccine Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. India Pandemic Influenza Vaccine Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Pandemic Influenza Vaccine Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. India Pandemic Influenza Vaccine Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Key Manufacturers of Pandemic Influenza Vaccine, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Pandemic Influenza Vaccine Revenue by Manufacturer, (US$ Million), 2018-2024
Table 12. Global Pandemic Influenza Vaccine Revenue Share by Manufacturer, 2018-2024
Table 13. Global Pandemic Influenza Vaccine Sales by Manufacturer, (M Units), 2018-2024
Table 14. Global Pandemic Influenza Vaccine Sales Share by Manufacturer, 2018-2024
Table 15. Global Pandemic Influenza Vaccine Price by Manufacturer (2018-2024) & (US$/Unit)
Table 16. Global Pandemic Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Pandemic Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pandemic Influenza Vaccine as of 2022)
Table 18. Global Key Manufacturers of Pandemic Influenza Vaccine, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Pandemic Influenza Vaccine, Product Offered and Application
Table 20. Global Key Manufacturers of Pandemic Influenza Vaccine, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Pandemic Influenza Vaccine in India, Ranked by Revenue (2022) & (US$ million)
Table 23. India Pandemic Influenza Vaccine Revenue by Players, (US$ Million), (2018-2024)
Table 24. India Pandemic Influenza Vaccine Revenue Share by Players, (2018-2024)
Table 25. India Pandemic Influenza Vaccine Sales by Players, (M Units), (2018-2024)
Table 26. India Pandemic Influenza Vaccine Sales Share by Players, (2018-2024)
Table 27. Global Pandemic Influenza Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 28. Global Pandemic Influenza Vaccine Sales in Volume by Region (2018-2024) & (M Units)
Table 29. Global Pandemic Influenza Vaccine Sales in Volume Forecast by Region (2024-2029) & (M Units)
Table 30. Global Pandemic Influenza Vaccine Sales in Value by Region (2018-2024) & (US$ Million)
Table 31. Global Pandemic Influenza Vaccine Sales in Value Forecast by Region (2024-2029) & (US$ Million)
Table 32. Americas Pandemic Influenza Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. Americas Pandemic Influenza Vaccine Sales in Value by Country (2018-2024) & (US$ Million)
Table 34. Americas Pandemic Influenza Vaccine Sales in Value by Country (2024-2029) & (US$ Million)
Table 35. Americas Pandemic Influenza Vaccine Sales in Volume by Country (2018-2024) & (M Units)
Table 36. Americas Pandemic Influenza Vaccine Sales in Volume by Country (2024-2029) & (M Units)
Table 37. EMEA Pandemic Influenza Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. EMEA Pandemic Influenza Vaccine Sales in Value by Country (2018-2024) & (US$ Million)
Table 39. EMEA Pandemic Influenza Vaccine Sales in Value by Country (2024-2029) & (US$ Million)
Table 40. EMEA Pandemic Influenza Vaccine Sales in Volume by Country (2018-2024) & (M Units)
Table 41. EMEA Pandemic Influenza Vaccine Sales in Volume by Country (2024-2029) & (M Units)
Table 42. APAC Pandemic Influenza Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. APAC Pandemic Influenza Vaccine Sales in Value by Country (2018-2024) & (US$ Million)
Table 44. APAC Pandemic Influenza Vaccine Sales in Value by Country (2024-2029) & (US$ Million)
Table 45. APAC Pandemic Influenza Vaccine Sales in Volume by Country (2018-2024) & (M Units)
Table 46. APAC Pandemic Influenza Vaccine Sales in Volume by Country (2024-2029) & (M Units)
Table 47. Sanofi Company Information
Table 48. Sanofi Description and Business Overview
Table 49. Sanofi Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 50. Sanofi Pandemic Influenza Vaccine Product
Table 51. Sanofi Recent Development
Table 52. CSL Company Information
Table 53. CSL Description and Business Overview
Table 54. CSL Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 55. CSL Pandemic Influenza Vaccine Product
Table 56. CSL Recent Development
Table 57. GSK Company Information
Table 58. GSK Description and Business Overview
Table 59. GSK Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 60. GSK Pandemic Influenza Vaccine Product
Table 61. GSK Recent Development
Table 62. Viatris Company Information
Table 63. Viatris Description and Business Overview
Table 64. Viatris Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 65. Viatris Pandemic Influenza Vaccine Product
Table 66. Viatris Recent Development
Table 67. AstraZeneca Company Information
Table 68. AstraZeneca Description and Business Overview
Table 69. AstraZeneca Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 70. AstraZeneca Pandemic Influenza Vaccine Product
Table 71. AstraZeneca Recent Development
Table 72. Hualan Bio Company Information
Table 73. Hualan Bio Description and Business Overview
Table 74. Hualan Bio Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 75. Hualan Bio Pandemic Influenza Vaccine Product
Table 76. Hualan Bio Recent Development
Table 77. Changchun Institute of Biological Company Information
Table 78. Changchun Institute of Biological Description and Business Overview
Table 79. Changchun Institute of Biological Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 80. Changchun Institute of Biological Pandemic Influenza Vaccine Product
Table 81. Changchun Institute of Biological Recent Development
Table 82. Sinovac Company Information
Table 83. Sinovac Description and Business Overview
Table 84. Sinovac Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 85. Sinovac Pandemic Influenza Vaccine Product
Table 86. Sinovac Recent Development
Table 87. BCHT Company Information
Table 88. BCHT Description and Business Overview
Table 89. BCHT Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 90. BCHT Pandemic Influenza Vaccine Product
Table 91. BCHT Recent Development
Table 92. Jiangsu GDK Company Information
Table 93. Jiangsu GDK Description and Business Overview
Table 94. Jiangsu GDK Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 95. Jiangsu GDK Pandemic Influenza Vaccine Product
Table 96. Jiangsu GDK Recent Development
Table 97. KM Biologics Company Information
Table 98. KM Biologics Description and Business Overview
Table 99. KM Biologics Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 100. KM Biologics Pandemic Influenza Vaccine Product
Table 101. KM Biologics Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Pandemic Influenza Vaccine Customers List
Table 105. Pandemic Influenza Vaccine Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Pandemic Influenza Vaccine Product Picture
Figure 2. Global Pandemic Influenza Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Pandemic Influenza Vaccine Market Size 2018-2029 (US$ Million)
Figure 4. Global Pandemic Influenza Vaccine Sales 2018-2029 (M Units)
Figure 5. India Pandemic Influenza Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 6. India Pandemic Influenza Vaccine Market Size 2018-2029 (US$ Million)
Figure 7. India Pandemic Influenza Vaccine Sales 2018-2029 (M Units)
Figure 8. India Pandemic Influenza Vaccine Market Share in Global, in Value (US$ Million) 2018-2029
Figure 9. India Pandemic Influenza Vaccine Market Share in Global, in Volume (M Units) 2018-2029
Figure 10. Pandemic Influenza Vaccine Report Years Considered
Figure 11. Product Picture of Trivalent Influenza Vaccine
Figure 12. Product Picture of Quadrivalent Influenza Vaccine
Figure 13. Global Pandemic Influenza Vaccine Market Share by Type in 2022 & 2029
Figure 14. Global Pandemic Influenza Vaccine Sales in Value by Type (2018-2029) & (US$ Million)
Figure 15. Global Pandemic Influenza Vaccine Sales Market Share in Value by Type (2018-2029)
Figure 16. Global Pandemic Influenza Vaccine Sales by Type (2018-2029) & (M Units)
Figure 17. Global Pandemic Influenza Vaccine Sales Market Share in Volume by Type (2018-2029)
Figure 18. Global Pandemic Influenza Vaccine Price by Type (2018-2029) & (US$/Unit)
Figure 19. India Pandemic Influenza Vaccine Market Share by Type in 2022 & 2029
Figure 20. India Pandemic Influenza Vaccine Sales in Value by Type (2018-2029) & (US$ Million)
Figure 21. India Pandemic Influenza Vaccine Sales Market Share in Value by Type (2018-2029)
Figure 22. India Pandemic Influenza Vaccine Sales by Type (2018-2029) & (M Units)
Figure 23. India Pandemic Influenza Vaccine Sales Market Share in Volume by Type (2018-2029)
Figure 24. India Pandemic Influenza Vaccine Price by Type (2018-2029) & (US$/Unit)
Figure 25. Product Picture of 6 Months to 3 Years
Figure 26. Product Picture of > 3 Years
Figure 27. Global Pandemic Influenza Vaccine Market Share by Application in 2022 & 2029
Figure 28. Global Pandemic Influenza Vaccine Sales in Value by Application (2018-2029) & (US$ Million)
Figure 29. Global Pandemic Influenza Vaccine Sales Market Share in Value by Application (2018-2029)
Figure 30. Global Pandemic Influenza Vaccine Sales by Application (2018-2029) & (M Units)
Figure 31. Global Pandemic Influenza Vaccine Sales Market Share in Volume by Application (2018-2029)
Figure 32. Global Pandemic Influenza Vaccine Price by Application (2018-2029) & (US$/Unit)
Figure 33. India Pandemic Influenza Vaccine Market Share by Application in 2022 & 2029
Figure 34. India Pandemic Influenza Vaccine Sales in Value by Application (2018-2029) & (US$ Million)
Figure 35. India Pandemic Influenza Vaccine Sales Market Share in Value by Application (2018-2029)
Figure 36. India Pandemic Influenza Vaccine Sales by Application (2018-2029) & (M Units)
Figure 37. India Pandemic Influenza Vaccine Sales Market Share in Volume by Application (2018-2029)
Figure 38. India Pandemic Influenza Vaccine Price by Application (2018-2029) & (US$/Unit)
Figure 39. Americas Pandemic Influenza Vaccine Sales in Volume Growth Rate 2018-2029 (M Units)
Figure 40. Americas Pandemic Influenza Vaccine Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 41. Americas Pandemic Influenza Vaccine Sales by Type (2018-2029) & (M Units)
Figure 42. Americas Pandemic Influenza Vaccine Sales Market Share in Volume by Type (2018-2029)
Figure 43. Americas Pandemic Influenza Vaccine Sales by Application (2018-2029) & (M Units)
Figure 44. Americas Pandemic Influenza Vaccine Sales Market Share in Volume by Application (2018-2029)
Figure 45. United States Pandemic Influenza Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 46. Canada Pandemic Influenza Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 47. Mexico Pandemic Influenza Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Pandemic Influenza Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 49. EMEA Pandemic Influenza Vaccine Sales in Volume Growth Rate 2018-2029 (M Units)
Figure 50. EMEA Pandemic Influenza Vaccine Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 51. EMEA Pandemic Influenza Vaccine Sales by Type (2018-2029) & (M Units)
Figure 52. EMEA Pandemic Influenza Vaccine Sales Market Share in Volume by Type (2018-2029)
Figure 53. EMEA Pandemic Influenza Vaccine Sales by Application (2018-2029) & (M Units)
Figure 54. EMEA Pandemic Influenza Vaccine Sales Market Share in Volume by Application (2018-2029)
Figure 55. Europe Pandemic Influenza Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 56. Middle East Pandemic Influenza Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 57. Africa Pandemic Influenza Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 58. China Pandemic Influenza Vaccine Sales in Volume Growth Rate 2018-2029 (M Units)
Figure 59. China Pandemic Influenza Vaccine Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 60. China Pandemic Influenza Vaccine Sales by Type (2018-2029) & (M Units)
Figure 61. China Pandemic Influenza Vaccine Sales Market Share in Volume by Type (2018-2029)
Figure 62. China Pandemic Influenza Vaccine Sales by Application (2018-2029) & (M Units)
Figure 63. China Pandemic Influenza Vaccine Sales Market Share in Volume by Application (2018-2029)
Figure 64. APAC Pandemic Influenza Vaccine Sales in Volume Growth Rate 2018-2029 (M Units)
Figure 65. APAC Pandemic Influenza Vaccine Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 66. APAC Pandemic Influenza Vaccine Sales by Type (2018-2029) & (M Units)
Figure 67. APAC Pandemic Influenza Vaccine Sales Market Share in Volume by Type (2018-2029)
Figure 68. APAC Pandemic Influenza Vaccine Sales by Application (2018-2029) & (M Units)
Figure 69. APAC Pandemic Influenza Vaccine Sales Market Share in Volume by Application (2018-2029)
Figure 70. Japan Pandemic Influenza Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 71. South Korea Pandemic Influenza Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 72. China Taiwan Pandemic Influenza Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 73. Southeast Asia Pandemic Influenza Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 74. India Pandemic Influenza Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 75. Pandemic Influenza Vaccine Value Chain
Figure 76. Pandemic Influenza Vaccine Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries